Global Trauma Implants Market Report to 2031 – Industry Analysis, Size, Share, Growth, Trends, and Forecasts

[view original post]

PR Newswire

Prolacta Bioscience Appoints David Steinberg as Chief Financial Officer

Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that top-ranked analyst David Steinberg has been appointed as chief financial officer. He will be responsible for overseeing Prolacta’s financial operations, including financial planning, reporting, accounting, business development, and investor relations.Steinberg brings nearly three decades of experience in biopharmaceutical equity res